Table 2. Clinicopathological Factors of AIM1/LINE1 Survival Analysis set (n=72).
| Clinicopathological Factors | ||||
|---|---|---|---|---|
|
| ||||
| Stage I/II (n = 23) |
Cox OS | Stage III (n=26) |
Stage IV (n=23) |
|
| Gender | NS | |||
| Male | 12 | 15 | 15 | |
| Female | 11 | 11 | 8 | |
|
| ||||
| Age (years) | p=0.0203, HR:1.15, 95%CI(1.02-1.30) |
|||
| Mean (SD) | 68.4 (±8.9) | 62.4 (±17.1) | 59.5 (±14.7) | |
|
| ||||
| Primary Site | NS | |||
| Extremities | 12 | |||
| Head/Neck | 6 | |||
| Trunk | 5 | |||
|
| ||||
| # Distant Sites | ||||
| 1 | 3 | |||
| 2 | 8 | |||
| 3+ | 12 | |||
|
| ||||
| Breslow Thickness | NS | |||
| ≤ 1.00mm | 8 | 3 | ||
| 1.01-2.00mm | 6 | 5 | ||
| 2.01-4.00mm | 6 | 8 | ||
| >4.00mm | 1 | 10 | ||
| Unknown | 2 | 0 | ||
|
| ||||
| Ulceration | NS | |||
| Present | 7 | 13 | ||
| Absent | 13 | 11 | ||
| Unknown | 3 | 2 | ||
|
| ||||
| Mitotic Index | NS | |||
| High ≥11/mm2 | 2 | |||
|
Intermediate 5-
10/mm2 |
1 | |||
| Low ≤4/mm2 | 17 | |||
| Unknown | 3 | |||
|
| ||||
| # Lymph Nodes (+) | ||||
| 1 | 7 | |||
| 2-3 | 13 | |||
| 4+ | 1 | |||
| 0 (Skin Met) | 2 | |||
| Unknown | 3 | |||
|
| ||||
| LINE1 or AIM1 | p=0.0282, HR:6.46, 95%CI(1.22-34.15) |
|||
| LINE1/AIM1 | 11 | 12 | 22 | |
| Neither | 12 | 14 | 1 | |